Get the Stockscreener App
1.14
6.54%
0.07
After Hours:
1.14
Vivani Medical Inc stock is traded at $1.14, with a volume of 246.21K.
It is up +6.54% in the last 24 hours and up +3.64% over the past month.
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
See More
Previous Close:
$1.07
Open:
$1.06
24h Volume:
246.21K
Relative Volume:
0.82
Market Cap:
$96.50M
Revenue:
-
Net Income/Loss:
$-26.61M
P/E Ratio:
-2.6723
EPS:
-0.4266
Net Cash Flow:
$-25.49M
1W Performance:
+7.55%
1M Performance:
+3.64%
6M Performance:
-13.64%
1Y Performance:
+10.68%
1-Day Range:
$1.06
$1.15
1-Week Range:
$1.01
$1.15
52-Week Range:
$0.9228
$1.92
Vivani Medical Inc Stock (VANI) Company Profile
Name
Vivani Medical Inc
Sector
Industry
Phone
415-506-8462
Address
1350 S. LOOP ROAD, ALAMEDA
Compare VANI vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VANI
Vivani Medical Inc
|
1.14 | 90.57M | 0 | -26.61M | -25.49M | -0.4266 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vivani Medical Inc Stock (VANI) Latest News
Vivani Medical, Inc. (NASDAQ:VANI) Sees Large Increase in Short Interest - MarketBeat
Sentiment Review: How is Vivani Medical Inc managing supply chain issues2026 Outlook & Technical Entry and Exit Tips - baoquankhu1.vn
Stock Analysis: Does Vivani Medical Inc have strong fundamentalsTrade Performance Summary & Free High Return Stock Watch Alerts - baoquankhu1.vn
VANI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Aug PostEarnings: Whats next for Affimed NV stockPortfolio Value Report & Fast Moving Stock Watchlists - baoquankhu1.vn
MACD Signal: Is Vivani Medical Inc a good ESG investment2026 Sector Review & Breakout Confirmation Alerts - baoquankhu1.vn
Analysis Recap: What dividend growth rate does Vivani Medical Inc offer2026 Recap & Weekly Momentum Picks - baoquankhu1.vn
Vivani Medical (VANI) upgraded to buy: What does it mean for the stock? - MSN
Aug Chart Watch: What is Vivani Medical Incs revenue forecast2026 Spike Watch & Target Return Focused Picks - baoquankhu1.vn
Vivani Medical, Inc. (U5P.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Vivani Medical (VANI) Receives Buy Rating Upgrade: What Are the Implications for the Stock? - bitget.com
Vivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
HC Wainwright Lifts Earnings Estimates for Vivani Medical - MarketBeat
Vivani Medical price target lowered to $3.50 from $4 at H.C. Wainwright - Yahoo Finance
HC Wainwright Cuts Vivani Medical (NASDAQ:VANI) Price Target to $3.50 - MarketBeat
Growth Value: Is Vivani Medical Inc stock a value trapTrade Signal Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn
Aug PostEarnings: Is Vivani Medical Inc a good ESG investment2026 Dividend Review & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Sentiment Watch: Can Vivani Medical Inc continue delivering strong returnsQuarterly Performance Summary & Weekly Setup with ROI Potential - baoquankhu1.vn
Vivani Medical (VANI) price target increased by 10.00% to 5.61 - MSN
Vivani Medical Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Vivani Medical Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Vivani Medical 2025 Financial Results Analysis - AlphaStreet
Vivani Medical: Advancing NanoPortal™ Drug Implants for Long-Acting Obesity and Diabetes Treatment - Minichart
Insider Buy: Will Vivani Medical Inc be affected by tariffs2026 Price Targets & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Vivani Medical (NASDAQ:VANI) Issues Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
VIVANI MEDICAL ($VANI) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
Vivani Medical: Q4 Earnings Snapshot - KVUE
Vivani Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Vivani Medical, Inc. Advances NPM-139 Semaglutide Implant toward Phase 1 Clinical Study Following Successful LIBERATE-1 Trial and Positive Preclinical Data - Quiver Quantitative
Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - ChartMill
Winners Losers: Is Vivani Medical Inc stock a value trapWeekly Market Summary & Precise Entry and Exit Recommendations - baoquankhu1.vn
Is Vivani Medical Inc stock a value trapWeekly Market Summary & Precise Entry and Exit Recommendations - baoquankhu1.vn
Vivani Medical (VANI) Projected to Post Quarterly Earnings on Monday - MarketBeat
Aug Highlights: Is Vivani Medical Inc a turnaround storyShare Buyback & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Aug Fed Impact: Is Vivani Medical Inc stock a value trapPrice Action & AI Driven Stock Reports - baoquankhu1.vn
Insider Stock Purchases: March 16, 2026 - Quiver Quantitative
Hedge Fund and Insider Trading News: Bill Ackman, Ray Dalio, Ken Griffin, Cliff Asness, Davidson Kempner, L1 Capital, Palliser Capital, Boone Capital, Millennium Management, GigaCloud Technology Inc (GCT), Vivani Medical Inc (VANI), and More - Insider Monkey
Guidance Update: Is Vivani Medical Inc a good ESG investmentQuarterly Trade Report & Consistent Profit Trading Strategies - baoquankhu1.vn
Vivani Medical shares are trading higher afte... - Benzinga
Insider Buying: Vivani Medical (NASDAQ:VANI) Director Purchases 1,575,231 Shares of Stock - MarketBeat
Vivani medical director Williams buys shares worth $1.68 million - Investing.com
Vivani medical director Williams buys shares worth $1.68 million By Investing.com - Investing.com South Africa
Vivani Medical Insider Bought Shares Worth $1,683,335, According to a Recent SEC Filing - marketscreener.com
Short Interest in Vivani Medical, Inc. (NASDAQ:VANI) Decreases By 25.4% - Defense World
Vivani Medical (VANI) Stock Analysis Report | Financials & Insights - Benzinga Japan
Vivani Medical (VANI) price target increased by 25.00% to 5.10 - MSN
Vivani Medical (NASDAQ:VANI) Stock Price Down 2.6%Should You Sell? - MarketBeat
Macro Review: How is Vivani Medical Inc managing supply chain issuesAnalyst Downgrade & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Market Overview: Should value investors consider Vivani Medical IncJuly 2025 Update & Safe Capital Growth Stock Tips - baoquankhu1.vn
VANI PE Ratio & Valuation, Is VANI Overvalued - Intellectia AI
Pullback Watch: Is Vivani Medical Inc stock a value trap2025 Sector Review & Free Reliable Trade Execution Plans - baoquankhu1.vn
Vivani Medical Inc Stock (VANI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Vivani Medical Inc Stock (VANI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Williams Gregg | Director |
Feb 15 '26 |
Buy |
1.06 |
1,866,492 |
1,983,333 |
29,781,952 |
| Williams Gregg | Director |
Jan 27 '26 |
Buy |
1.48 |
1,351,351 |
1,999,999 |
27,915,460 |
| Williams Gregg | Director |
Jan 15 '26 |
Buy |
1.14 |
1,737,765 |
1,983,334 |
26,564,109 |
| Mendelsohn Aaron | Director |
Dec 29 '25 |
Buy |
1.23 |
20,000 |
24,600 |
188,170 |
| Williams Gregg | Director |
Dec 15 '25 |
Buy |
1.14 |
1,737,765 |
1,983,334 |
24,826,344 |
| Williams Gregg | Director |
Nov 15 '25 |
Buy |
1.14 |
1,737,764 |
1,983,333 |
23,088,579 |
| Williams Gregg | Director |
Oct 27 '25 |
Buy |
1.62 |
3,703,703 |
5,999,999 |
21,350,815 |
| Williams Gregg | Director |
Oct 15 '25 |
Buy |
1.14 |
1,737,764 |
1,983,333 |
17,647,112 |
| Williams Gregg | Director |
Sep 15 '25 |
Buy |
1.16 |
2,068,453 |
2,400,001 |
15,909,348 |
| Williams Gregg | Director |
May 15 '25 |
Buy |
1.01 |
6,836 |
6,904 |
13,838,490 |
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):